Stocks Comparison
Dexcom vs Solventum: revenue, profit, margins and growth compared
Dexcom brought in $4.7B of revenue in fiscal 2025, Solventum $8.3B in fiscal 2025. Revenue changed by +15.6% at Dexcom and +0.9% at Solventum on the year before, so Dexcom grew faster. Dexcom kept 17.9% of its revenue as net profit, Solventum 18.7%. Free cash flow was $1.1B at Dexcom and -$10M at Solventum.
Side by side, latest fiscal year
| DXCM | SOLV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $4.7B | $8.3B |
| Revenue growth | +15.6% | +0.9% |
| Net income | $836.3M | $1.6B |
| Net margin | 17.9% | 18.7% |
| Free cash flow | $1.1B | -$10M |
| Free cash flow margin | 23.1% | -0.1% |
| Earnings per share (diluted) | $2.09 | $8.88 |
| Cash | $917.7M | $878M |
| Debt | n/a | $5B |
| Price to earnings | 41.4 | 10.1 |
| Market value | $32.7B | $15.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #65 of 523 · Health care | #49 of 523 · Health care |
Over the years
Questions about Dexcom and Solventum
Which is bigger by revenue, Dexcom or Solventum?
Solventum is bigger by revenue: $8.3B in fiscal 2025, against $4.7B for Dexcom in fiscal 2025.
Which keeps more of its revenue as profit, Dexcom or Solventum?
Dexcom had a net margin of 17.9% in fiscal 2025; Solventum had 18.7% in fiscal 2025.
Which grew revenue faster, Dexcom or Solventum?
In their latest fiscal years revenue changed by +15.6% at Dexcom and +0.9% at Solventum.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.